Knockdown of ubiquitin ligases in glioblastoma cancer stem cells leads to cell death and differentiation

Journal of Biomolecular Screening

Volumn 17, Issue 2, 2012, Pages 152-162

  Low, Jonathan ^a   Blosser, Wayne ^a   Dowless, Michele ^a   Ricci Vitiani, Lucia ^b   Pallini, Roberto ^c   De Maria, Ruggero ^b   Stancato, Louis ^a  

^a ELI LILLY AND COMPANY   (United States)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^c CATHOLIC UNIVERSITY   (Italy)

Author keywords

cancer stem cell; glioblastoma; high content imaging; ubiquitin ligase

Indexed keywords

SHORT HAIRPIN RNA; UBIQUITIN PROTEIN LIGASE;

APOPTOSIS; ARTICLE; CANCER STEM CELL; CELL DEATH; CELL DIFFERENTIATION; CELL ISOLATION; CELL SUBPOPULATION; CLINICAL ASSESSMENT TOOL; CLINICAL EXAMINATION; CONTROLLED STUDY; GENE SILENCING; GLIOBLASTOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMAGING; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROGENY;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BORONIC ACIDS; CELL CYCLE; CELL DIFFERENTIATION; CELL LINE, TUMOR; GENE KNOCKDOWN TECHNIQUES; GLIOBLASTOMA; HUMANS; NEOPLASTIC STEM CELLS; NOCODAZOLE; PYRAZINES; RNA INTERFERENCE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; UBIQUITIN-PROTEIN LIGASES;

EID: 84856275188     PISSN: 10870571     EISSN: 1552454X     Source Type: Journal    
DOI: 10.1177/1087057111422565     Document Type: Article

References (27)

1. Gregori L., Poosch M. S., Cousins G., Chau V.. A Uniform Isopeptide-Linked Multiubiquitin Chain Is Sufficient to Target Substrate for Degradation in Ubiquitin-Mediated Proteolysis. J. Biol. Chem. 1990 ; 265: 8354-8357
2. Pickart C. M.. Mechanisms Underlying Ubiquitination. Annu. Rev. Biochem. 2001 ; 70: 503-533 (Pubitemid 32663902)
3. Ciechanover A., Elias S., Heller H., Ferber S., Hershko A.. Characterization of the Heat-Stable Polypeptide of the ATP-Dependent Proteolytic System from Reticulocytes. J. Biol. Chem. 1980 ; 255: 7525-7528 (Pubitemid 11239454)
4. Hershko A., Heller H., Elias S., Ciechanover A.. Components of Ubiquitin-Protein Ligase System: Resolution, Affinity Purification, and Role in Protein Breakdown. J. Biol. Chem. 1983 ; 258: 8206-8214
5. Hoeller D., Dikic I.. Targeting the Ubiquitin System in Cancer Therapy. Nature. 2009 ; 458: 438-444
6. Nalepa G., Rolfe M., Harper J. W.. Drug Discovery in the Ubiquitin-Proteasome System. Nat. Rev. Drug Discov. 2006 ; 5: 596-613
7. Popat R., Joel S., Oakervee H., Cavenagh J.. Bortezomib for Multiple Myeloma. Expert Opin. Pharmacother. 2006 ; 7: 1337-1346
8. Adams J., Kauffman M.. Development of the Proteasome Inhibitor Velcade (Bortezomib). Cancer Invest. 2004 ; 22: 304-311 (Pubitemid 38725184)
9. Singh S. K., Hawkins C., Clarke I. D., Squire J. A., Bayani J., Hide T., Henkelman R. M., Cusimano M. D., Dirks P. B.. Identification of Human Brain Tumour Initiating Cells. Nature. 2004 ; 432: 396-401 (Pubitemid 39551674)
10. Galli R., Binda E., Orfanelli U., Cipelletti B., Gritti A., De Vitis S., Fiocco R., Foroni C., Dimeco F., Vescovi A.. Isolation and Characterization of Tumorigenic, Stem-Like Neural Precursors from Human Glioblastoma. Cancer Res. 2004 ; 64: 7011-7021 (Pubitemid 39331011)
11. Stupp R., Weber D. C.. The Role of Radio- and Chemotherapy in Glioblastoma. Onkologie. 2005 ; 28: 315-317 (Pubitemid 40827485)
12. Eramo A., Ricci-Vitiani L., Zeuner A., Pallini R., Lotti F., Sette G., Pilozzi E., Larocca L. M., Peschle C., De Maria R.. Chemotherapy Resistance of Glioblastoma Stem Cells. Cell Death Differ. 2006 ; 13: 1238-1241 (Pubitemid 43905604)
13. Quick A., Patel D., Hadziahmetovic M., Chakravarti A., Mehta M.. Current Therapeutic Paradigms in Glioblastoma. Rev. Recent Clin. Trials. 2010 ; 5: 14-27
14. Pallini R., Ricci-Vitiani L., Banna G. L., Signore M., Lombardi D., Todaro M., Stassi G., Martini M., Maira G., Larocca L. M., et al. Cancer Stem Cell Analysis and Clinical Outcome in Patients with Glioblastoma Multiforme. Clin. Cancer Res. 2008 ; 14: 8205-8212
15. Ricci-Vitiani L., Pallini R., Biffoni M., Todaro M., Invernici G., Cenci T., Maira G., Parati E. A., Stassi G., Larocca L. M., et al. Tumour Vascularization via Endothelial Differentiation of Glioblastoma Stem-Like Cells. Nature. 2010 ; 468: 824-828
16. Low J., Huang S., Blosser W., Dowless M., Burch J., Neubauer B., Stancato L.. High-Content Imaging Characterization of Cell Cycle Therapeutics through In Vitro and In Vivo Subpopulation Analysis. Mol. Cancer Ther. 2008 ; 7: 2455-2463
17. Ponten J., Macintyre E. H.. Long Term Culture of Normal and Neoplastic Human Glia. Acta Pathol. Microbiol. Scand. 1968 ; 74: 465-486
18. Ponten J., Saksela E.. Two Established In Vitro Cell Lines from Human Mesenchymal Tumours. Int. J. Cancer. 1967 ; 2: 434-447
19. Porter L. A., Cukier I. H., Lee J. M.. Nuclear Localization of Cyclin B1 Regulates DNA Damage-Induced Apoptosis. Blood. 2003 ; 101: 1928-1933 (Pubitemid 36237595)
20. Chang D. C., Xu N., Luo K. Q.. Degradation of Cyclin B Is Required for the Onset of Anaphase in Mammalian Cells. J. Biol. Chem. 2003 ; 278: 37865-37873 (Pubitemid 37175315)
21. Srinivasan A., Roth K. A., Sayers R. O., Shindler K. S., Wong A. M., Fritz L. C., Tomaselli K. J.. In Situ Immunodetection of Activated Caspase-3 in Apoptotic Neurons in the Developing Nervous System. Cell Death Differ. 1998 ; 5: 1004-1016 (Pubitemid 29008214)
22. Bonvini P., Zorzi E., Basso G., Rosolen A.. Bortezomib-Mediated 26S Proteasome Inhibition Causes Cell-Cycle Arrest and Induces Apoptosis in CD-30+ Anaplastic Large Cell Lymphoma. Leukemia. 2007 ; 21: 838-842 (Pubitemid 46444582)
23. Low J., Dowless M., Shiyanova T., Rowlinson S., Ricci-Vitiani L., de Maria R., Pallini R., Stancato L.. Knockdown of Cancer Testis Antigens Modulates Neural Stem Cell Marker Expression in Glioblastoma Tumor Stem Cells. J. Biomol. Screen. 2010 ; 15: 830-839
24. Low J., Chakravartty A., Blosser W., Dowless M., Chalfant C., Bragger P., Stancato L.. Phenotypic Fingerprinting of Small Molecule Cell Cycle Kinase Inhibitors for Drug Discovery. Curr. Chem. Genomics. 2009 ; 3: 13-21
25. Cohen P., Tcherpakov M.. Will the Ubiquitin System Furnish as Many Drug Targets as Protein Kinases?. Cell. 2010 ; 143: 686-693
26. Vassilev L. T., Vu B. T., Graves B., Carvajal D., Podlaski F., Filipovic Z., Kong N., Kammlott U., Lukacs C., Klein C., et al. In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2. Science. 2004 ; 303: 844-848 (Pubitemid 38174664)
27. Nicholson J., Hupp T. R.. The Molecular Dynamics of MDM2. Cell Cycle. 2010 ; 9: 1878-1881